Theravance Biopharma, Inc. (27) | Note Agreements (1)

Recent Contracts

Form of Note Purchase Agreement, dated February 21, 2020 by and among Theravance Biopharma R&D, Inc., Triple Royalty Sub II LLC, and the Purchasers (Filed With SEC on February 27, 2020)